# Patient-derived Organoids of Lung Cancer to Test Drug Response

> **NCT03979170** · — · RECRUITING · sponsor: **University Hospital, Geneva** · enrollment: 50 (estimated)

## Conditions studied

- Lung Cancer
- Organoid

## Interventions

- **PROCEDURE:** Lung tumor resection

## Key facts

- **NCT ID:** NCT03979170
- **Lead sponsor:** University Hospital, Geneva
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2019-04-01
- **Primary completion:** 2026-12-30
- **Final completion:** 2029-12-30
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03979170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03979170, "Patient-derived Organoids of Lung Cancer to Test Drug Response". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03979170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*